ResearcherShanghai Jiao Tong UniversityNo recent work listed
Nannan Zheng
Matched on ORCID iD 0009-0009-7466-5340; OpenAlex author ID A5032666798. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2018: 1 paper · 2019: none · 2020: 1 paper
Papers 2
- Combining protein arginine methyltransferase inhibitor and anti-programmed death-ligand-1 inhibits pancreatic cancer progression. Co-author DOI 10.3748/wjg.v26.i26.3737↗
- Effect of photodynamic therapy with (17R,18R)-2-(1-hexyloxyethyl)-2-devinyl chlorine E6 trisodium salt on pancreatic cancer cells in vitro and in vivo. Co-author DOI 10.3748/wjg.v24.i46.5246↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yi Zhang · 2 shared papers, 2018–2020 · strength 0.19
- Paper Combining protein arginine methyltransferase inhibitor and anti-programmed death-ligand-1 inhibits pancreatic cancer pr… DOI 10.3748/wjg.v26.i26.3737↗
- Paper Effect of photodynamic therapy with (17R,18R)-2-(1-hexyloxyethyl)-2-devinyl chlorine E6 trisodium salt on pancreatic ca… DOI 10.3748/wjg.v24.i46.5246↗
- Leiming Xu · 2 shared papers, 2018–2020 · strength 0.19
- Paper Combining protein arginine methyltransferase inhibitor and anti-programmed death-ligand-1 inhibits pancreatic cancer pr… DOI 10.3748/wjg.v26.i26.3737↗
- Paper Effect of photodynamic therapy with (17R,18R)-2-(1-hexyloxyethyl)-2-devinyl chlorine E6 trisodium salt on pancreatic ca… DOI 10.3748/wjg.v24.i46.5246↗
- Fang Zhen Sun · 2 shared papers, 2018–2020 · strength 0.19
- Paper Combining protein arginine methyltransferase inhibitor and anti-programmed death-ligand-1 inhibits pancreatic cancer pr… DOI 10.3748/wjg.v26.i26.3737↗
- Paper Effect of photodynamic therapy with (17R,18R)-2-(1-hexyloxyethyl)-2-devinyl chlorine E6 trisodium salt on pancreatic ca… DOI 10.3748/wjg.v24.i46.5246↗
- Yujie Shen · 1 shared paper, 2018 · strength 0.07
- Jia Cao · 1 shared paper, 2018 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.